Income and Education Affect Prognosis and Treatment in Symptomatic Myeloma: A Population-Based Study on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

被引：0
|
作者：
Larfors, Gunnar [1 ]
Carlson, Kristina Elisabet [1 ,2 ]
Day, Christopher [3 ]
Einarsdottir, Sigrun [4 ]
Juliusson, Gunnar [5 ]
Karma, Moshtak [6 ]
Knut-Bojanowska, Dorota [7 ]
Sverrisdottir, Ingigerdur [3 ,8 ]
Turesson, Ingemar [9 ]
Scivetti, Mariana Villegas [3 ]
Blimark, Cecilie Hveding [3 ,4 ]
机构：
[1] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[2] Uppsala Univ, Uppsala, Sweden
[3] Sahlgrens Univ Hosp, Dept Haematol & Coagulat, Gothenburg, Sweden
[4] Univ Gothenburg, Dept Med & Clin Nutr, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden
[5] Lund Univ & Hosp, Lund Stem Cell Ctr, Lund, Sweden
[6] Sodra Alvsborg Hosp, Dept Haematol, Boras, Sweden
[7] Uddevalla Cent Hosp, Dept Haematol, Uddevalla, Sweden
[8] Univ Iceland, Fac Med, Reykjavik, Iceland
[9] Skane Univ Hosp, Malmo, Sweden
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180637
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients
    Branvall, Elsa
    Ekberg, Sara
    Eloranta, Sandra
    Wasterlid, Tove
    Birmann, Brenda M.
    Smedby, Karin E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (06) : 652 - 661
  • [22] Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry
    Redder, Louise
    Klausen, Tobias Wirenfeldt
    Vangsted, Annette Juul
    Gregersen, Henrik
    Andersen, Niels Frost
    Pedersen, Robert Schou
    Plesner, Torben
    Frederiksen, Mikael
    Frolund, Ulf Christian
    Helleberg, Carsten
    Nielsen, Lene Kongsgaard
    Salomo, Morten
    Gimsing, Peter
    Frederiksen, Henrik
    Abildgaard, Niels
    BLOOD, 2019, 134
  • [23] Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry
    Redder, Louise
    Klausen, Tobias W.
    Vangsted, Annette Juul
    Gregersen, Henrik
    Andersen, Niels F.
    Pedersen, Robert S.
    Szabo, Agoston G.
    Frederiksen, Mikael
    Frolund, Ulf C.
    Helleberg, Carsten
    Nielsen, Lene Kongsgaard
    Pedersen, Per T.
    Salomo, Morten
    Gimsing, Peter
    Frederiksen, Henrik
    Abildgaard, Niels
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) : 119 - 124
  • [24] WHEN PERFORMANCE OF CYTOGENETICS MATTERS: A POPULATION-BASED STUDY IN THE NETHERLANDS ON NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Brink, M.
    Visser, O.
    Minnema, M. C.
    Zweegman, S.
    Sonneveld, P.
    Dinmohamed, A. G.
    HAEMATOLOGICA, 2017, 102 : 273 - 273
  • [25] Fractures and survival in multiple myeloma: results from a population-based study
    Thorsteinsdottir, Sigrun
    Gislason, Gauti
    Aspelund, Thor
    Sverrisdottir, Ingigerdur
    Landgren, Ola
    Turesson, Ingemar
    Bjorkholm, Magnus
    Kristinsson, Sigurdur Y.
    HAEMATOLOGICA, 2020, 105 (04) : 1067 - 1073
  • [26] THE SWEDISH MULTIPLE MYELOMA REGISTER: MEDIAN 5-YEAR SURVIVAL OF 7.3 YEARS IN PATIENTS 65 YEARS AND YOUNGER, POPULATION-BASED DATA ON 3,876 MULTIPLE MYELOMA PATIENTS DIAGNOSED 2008-2013
    Blimark, C. H.
    Genell, A.
    Juliusson, G.
    Nahi, H.
    Forsberg, K.
    Turesson, I.
    Ahlberg, L.
    Linder, O.
    Carlsson, K.
    Bjorkstrand, B.
    Kristinsson, S. Y.
    HAEMATOLOGICA, 2016, 101 : 522 - 522
  • [27] Association between the multiple myeloma treatments and vascular adverse events in Taiwanese multiple myeloma patients: A population-based cohort study
    Chen, Mei-Tsen
    Huang, Shih-Tsung
    Ko, Bor-Sheng
    Huang, Huai-Hsuan
    Hsiao, Fei-Yuan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 150 - 150
  • [28] The impact of marginalization on treatment receipt and overall survival in newly diagnosed multiple myeloma patients in Ontario: a population-based cohort study
    Visram, Alissa
    Seow, Hsien
    Fiala, Mark
    Gayowsky, Anastasia
    Pond, Gregory
    Mian, Hira
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S25 - S26
  • [29] Secondary Malignancies in Multiple Myeloma in Korean Patients: A Nationwide Population-Based Study
    Park, Boyoung
    Lee, Eunyoung
    Yoon, Junghyun
    Park, Youngju
    Eom, Hyeon-Seok
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 936 - 944
  • [30] Restoration of renal function in patients with newly diagnosed multiple myeloma is not associated with improved survival: a population-based study
    de Vries, Joost C.
    Oortgiesen, Berdien
    Hemmelder, Marc H.
    van Roon, Eric
    Kibbelaar, Robby E.
    Veeger, Nic
    Hoogendoorn, Mels
    LEUKEMIA & LYMPHOMA, 2017, 58 (09) : 2101 - 2109
12345